$NGNE
Neurogene, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$26.85
▲+1.32%+$0.350
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateNeurogene, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is NGNE up today? It is at $26.85 (+0.00%), and our scanner flagged it 50 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment NGNE spikes, and full due diligence on NGNE — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $NGNE 50 times in the last 30 days. Create a free account to track $NGNE, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on NGNE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NGNE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
The company can keep selling new shares into the market. Size not stated in the filing.
Some filings did not state a size, so these are floors.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
4,166,666 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $117.2M in size · Priced at $30/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Mcminn Rachel Officer | Other | 756 | added <0.1% | 1.35M | $19K at $25.32 | Sep 22, 26 |
Cvijic Christine Mikail Officer | Sold (automatic/other) | -4K 0.02% of company | sold 4.8% | 84K | $152K at $36.13 | Jul 7, 26 |
Cvijic Christine Mikail Officer | Sold (automatic/other) | -600 | sold 0.7% | 88K | $22K at $36.02 | Jul 6, 26 |
Cvijic Christine Mikail Officer | Sold (automatic/other) | -4K 0.02% of company | sold 4.4% | 89K | $140K at $34.58 | Jul 2, 26 |
Cvijic Christine Mikail Officer | Sold (automatic/other) | -739 | sold 0.8% | 93K | $25K at $34.06 | Jul 1, 26 |
Cvijic Christine Mikail Officer | Sold (automatic/other) | -10K 0.05% of company | sold 9.3% | 94K | $289K at $30.07 | May 6, 26 |
Mcminn Rachel Officer | Sold (automatic/other) | -3K 0.02% of company | sold 0.2% | 1.34M | $74K at $22.07 | Mar 26, 26 |
Jordan Julie Officer | Sold (automatic/other) | -828 | sold 6.2% | 12K | $18K at $21.89 | Mar 26, 26 |
Cvijic Christine Mikail Officer | Sold (automatic/other) | -3K 0.01% of company | sold 2.4% | 103K | $55K at $21.62 | Mar 26, 26 |
Cvijic Christine Mikail Officer | Sold (automatic/other) | -4K 0.02% of company | sold 3.7% | 106K | $83K at $20.42 | Mar 13, 26 |
Cobb Stuart Officer | Sold (automatic/other) | -7K 0.03% of company | sold 18% | 30K | $139K at $20.41 | Mar 13, 26 |
Cvijic Christine Mikail Officer | Sold (automatic/other) | -5K 0.02% of company | sold 4.2% | 110K | $121K at $25.11 | Feb 27, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on NGNE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NGNE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
NGNE last traded at $26.85, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Neurogene, Inc. Common Stock (NGNE) is next expected to report earnings on Thursday, November 12, 2026, about 34 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The NGNE Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged NGNE 50 times in the last 30 days.
NGNE (Neurogene, Inc. Common Stock) trades on XNAS, with a market cap of about $530M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge NGNE for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$NGNE discussion
Sign in to ask a question or join the discussion.